ClinConnect ClinConnect Logo
Search / Trial NCT06193655

Test-retest Reproducibility of Right Heart Parameters of Chamber Size and Function

Launched by ISTITUTO AUXOLOGICO ITALIANO · Jan 4, 2024

Trial Information

Current as of August 22, 2025

Not yet recruiting

Keywords

Right Ventricle Right Atrium Echocardiography Cardiac Magnetic Resonance Reproducibility

ClinConnect Summary

This clinical trial is focused on understanding how reliable certain heart measurements are when taken multiple times, specifically looking at the right side of the heart. Researchers want to see how consistent advanced imaging techniques, like echocardiography (a type of ultrasound for the heart) and cardiac magnetic resonance (CMR), are when they measure the size and function of the right ventricle (RV), right atrium (RA), and tricuspid annulus (the part of the heart that connects the right atrium to the right ventricle). This is important because knowing how reliable these measurements are can help doctors track changes in heart function over time, which is essential for patient care and treatment evaluation.

To participate in this study, you need to be at least 18 years old and be able to give informed consent. However, there are some exclusions, like if you are pregnant, have certain heart devices, or if you have specific heart conditions that could complicate the study. If you join, you can expect to undergo a few imaging tests to assess your heart's function and size, which will help researchers gather important information about the right side of the heart. The trial is not yet recruiting participants, but it aims to provide valuable insights into heart health and improve future care for patients with right heart issues.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age over 18 years old
  • Informed consent
  • Exclusion Criteria:
  • Age \<18 years old
  • Pregnancy/breast feeding
  • Tricuspid valve repair/prosthesis
  • Pacemaker or implantable cardiac defibrillator
  • Complex congenital diseases (exceptions: bicuspid aortic valve, atrial septal defect, ventricular septal defect, corrected tetralogy of Fallot)
  • Poor acoustic window
  • Inability to acquire 3D datasets with at least 20 volumes/s
  • Very irregular R-R interval
  • Claustrophobia
  • Acute conditions
  • Hemodynamically instable patients
  • Patients who do not provide consent for the study protocol

About Istituto Auxologico Italiano

Istituto Auxologico Italiano is a prominent Italian research institute dedicated to advancing medical science and improving patient care through innovative clinical research. With a strong focus on metabolic diseases, cardiovascular health, and neuropsychological disorders, the institute integrates clinical practice with cutting-edge research to foster the development of new therapeutic strategies. Committed to ethical standards and patient safety, Istituto Auxologico Italiano collaborates with various national and international partners, contributing significantly to the global medical community while ensuring high-quality care and support for its patients.

Locations

Patients applied

0 patients applied

Trial Officials

Gianluca Pontone

Study Director

Centro Cardiologico Monzino

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported